| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $844.6M | +1.3% |
| Cost of Revenue | $423.9M | +7.5% |
| Gross Profit | $420.7M | -4.3% |
| R&D Expense | $178.9M | -0.6% |
| SG&A Expense | $64.2M | -6.5% |
| Operating Income | -$3.3M | -119.7% |
| Pre-tax Income | -$45.1M | +2.1% |
| Income Tax | -$84.7M | -1137.7% |
| Net Income | $39.6M |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $96.4M | +9.8% |
| Accounts Receivable | $231.9M | -9.0% |
| Inventory | $78.8M | -0.5% |
| Current Assets | $454.5M | -2.0% |
| Total Assets | $1.21B | +4.3% |
| Current Liabilities | $315.5M | -4.1% |
| Long-term Debt | $342.1M | -1.8% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $51.4M | +2.3% |
| Capital Expenditures | $25.3M | +13.1% |
| Investing Cash Flow | -$25.3M | -10.8% |
| Financing Cash Flow | -$19.4M | -151.5% |
| Free Cash Flow | $26.1M | -6.4% |
| +173.1% |
| EPS (Basic) | $0.22 | +171.0% |
| EPS (Diluted) | $0.22 | +171.0% |
| Total Liabilities |
| $763.3M |
| +0.7% |
| Stockholders' Equity | $449.0M | +11.0% |